维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="OSHIRO C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Epigenetic silencing of DSC3is a common event in human breast cancer显示文摘	OSHIRO M M KIM C J WOZNIAK R J	2005	Breast Cancer Research2005，7，：	1
2	PIK3CA mutations in serumDNA are predictive of recurrence in primary breast cancer pa- tients 显示文摘	Oshiro C Kagara N Naoi Y	2015	Breast Cancer Res Treat2015，150，2：	1
3	Doxorubicin pathways: pharmacodynamics and adverse effects 显示文摘	THORN C F OSHIRO C MARSH S	2011	Pharmacogenet Genomics2011，21，7：	1
4	Microglia and astroglia prevent oxidative stress-induced neuronal cell death: Implications for aceruloplasminemia显示文摘	Oshiro S Kawamura K Zhang C Sone T Morioka MS Kobayashi S	2008	Biochem Biophys Acta2008，1782，2：	1
5	Role of perilymphatic fistulain sudden hearing loss : an animal model 显示文摘	Oshiro EM Shelton C Lusted HS	1989	Ann Otol RhinolLaryngol1989，98，49：	1
6	PIK3CA mutations inserum DNA are predictive of recurrence in primary breast cancerpatients显示文摘	OSHIRO C KAGARA N NAOI Y	2015	Breast Cancer Res Treat2015，150，2：	1
7	Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects显示文摘	Takasu N Oshiro C Akamine H	1997	Journal of Endocrinological Investigation1997，20，8：	1
8	Triglyceride,but not total cholesterol or low-density lipoprotein cholesterol levels,predict development of proteinuria显示文摘	TOZAWA M ISEKI K OSHIRO C		0，，05：	1
9	Thyroid-stimulating anti- body and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal ubjects显示文摘	Takasu N Oshiro C Akamine H	1997	J Endocrinol Invest1997，20，8：	1
10	Role of perilymphatic fistula in sudden hearing loss显示文摘	Oshiro EM Shelton C Lusted HS	1989	Ann Otol Rhino Laryngol1989，98，：	1
11	Seventeen alpha-hydroxylase deficiency with one base pair deletion of the cytochrome P450c17 (CYP17) gene显示文摘	Takasu N Wakugami T	1995	Clin Endocrinol Metab1995，80，8：	1
12	A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy显示文摘	Oshiro C Arai T Kamiqaki S	2012	Gan To Kagaku Ryoho2012，39，2：	1
13	Genetic Diversity in Yeast Assessed With Whole - Genome Oligonucleotide Arrays显示文摘	Winzeler E A Castillo - Davis C I Oshiro G	2003	Genetics2003，，163：	1
14	Doxorubicin pathways: pharmacodynamics and adverse effects显示文摘	Thorn CF Oshiro C Marsh S	2011	Pharmacogenet Genomics2011，21，：	1
15	Multiple risk factor clustering of hypertension in a screened cohort显示文摘	Tozawa M Oshiro S Iseki C	2000	Journal of Hypertension2000，18，10：	1
16	Epigenetic silencing of DSC3 is a common event in human breast cancer显示文摘	Oshiro M M Kim C J Wozniak R J Junk D J Mufioz-Rodriguez J L Burr J A	2005	Breast Cancer Res2005，7，：	1
17	Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria显示文摘	Tozawa M Iseki K Oshiro C	2002	Kidney Int2002，62，：	1
18	Assessment of nausea and vomiting during FEC regimen for breast cancer after the novel antiemetic agent-introduction using MASCC antiemesis tool显示文摘	Oshiro C Kamigaki S Nakamura Y		0，，：	1
19	Multiple risk factor clustering of hypertension in a screened cohort 显示文摘	Tozawa M Oshiro S lseki C	2000	Journal of hypertension2000，18，10：	1
20	Thyroid - stimulating antibody and TSH -binding inhibitor immunoglobulin in 277Graves' patients and in 686 normal subjects显示文摘	Takasu N Oshiro C Akamine H	1997	J Endocrinol Invest1997，20，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示